New and experimental treatments of vitiligo and other hypomelanoses.
This article deals with new and experimental treatments that can be used to treat various forms of depigmenting disorders. Ultraviolet B-focused therapies and new surgical approaches are analyzed in this article. These therapies were mainly or only developed to treat vitiligo, which is the most studied and probably the most challenging of all the hypomelanoses, but the results obtained in trials and clinical experiences about vitiligo sometimes can be referred to other depigmenting disorders.
Lotti
Torello
T
Department of Dermatological Sciences, University of Florence, Via Lorenzo il Magnifico, 104, 50129, Florence, Italy. torello.lotti@unifi.it
Prignano
Francesca
F
Buggiani
Gionata
G
D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use; D017496:Hypopigmentation / Q000532:radiotherapy / Q000628:therapy*; D015603:Keratinocytes / Q000637:transplantation; D053685:Laser Therapy; D008544:Melanocytes / Q000637:transplantation; D010789:Phototherapy / Q000379:methods; D012880:Skin Pigmentation / Q000187:drug effects; D016038:Skin Transplantation; D014467:Ultraviolet Therapy / Q000379:methods; D014820:Vitiligo / Q000532:radiotherapy / Q000628:therapy*
D003879:Dermatologic Agents; D006873:Hydroquinones; C006429:monobenzone